Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau

  • 작성자한진
  • 작성일2007-06-25 18:01:45
  • 조회수3084
Age-related neurodegenerative disease has been mechanistically linked with mitochondrial dysfunction via damage from reactive oxygen species produced within the cell. We determined whether increased mitochondrial oxidative stress could modulate or regulate two of the key neurochemical hallmarks of Alzheimer's disease (AD): tau phosphorylation, and ß-amyloid deposition. Mice lacking superoxide dismutase 2 (SOD2) die within the first week of life, and develop a complex heterogeneous phenotype arising from mitochondrial dysfunction and oxidative stress. Treatment of these mice with catalytic antioxidants increases their lifespan and rescues the peripheral phenotypes, while uncovering central nervous system pathology. We examined sod2 null mice differentially treated with high and low doses of a catalytic antioxidant and observed striking elevations in the levels of tau phosphorylation (at Ser-396 and other phospho-epitopes of tau) in the low-dose antioxidant treated mice at AD-associated residues. This hyperphosphorylation of tau was prevented with an increased dose of the antioxidant, previously reported to be sufficient to prevent neuropathology. We then genetically combined a well-characterized mouse model of AD (Tg2576) with heterozygous sod2 knockout mice to study the interactions between mitochondrial oxidative stress and cerebral Aß load. We found that mitochondrial SOD2 deficiency exacerbates amyloid burden and significantly reduces metal levels in the brain, while increasing levels of Ser-396 phosphorylated tau. These findings mechanistically link mitochondrial oxidative stress with the pathological features of AD. Simon Melov1*, Paul A. Adlard2, Karl Morten1, Felicity Johnson1, Tamara R. Golden1, Doug Hinerfeld1, Birgit Schilling1, Christine Mavros2, Colin L. Masters2, Irene Volitakis2, Qiao-Xin Li2, Katrina Laughton2, Alan Hubbard3, Robert A. Cherny2, Brad Gibson1, Ashley I. Bush2,4* 1 Buck Institute for Age Research, Novato, California, United States of America, 2 Mental Health Research Institute of Victoria, and Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia, 3 School of Public Health, EHS/Biostatistics, University of California Berkeley, Berkeley, California, United States of America, 4 Department of Psychiatry, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America (Journal article originally published in PLoS. Open Access.)
Total405 [ page1/27 ]
No. 제목 작성자 작성일 조회수
405 인제대 의과대학 김형규 교수, 생리학 분야 최고 학술상 수상 2023.11.09 관리자 2023.11.09 15
404 인제대, 과기정통부 ‘2023년도 기초연구실 지원사업’ 선정 2023.09.13 관리자 (web_admin) 2023.09.13 57
403 인제대 교수팀 '돌연사 주범 심부전 원인 규명' 2023.09.13 관리자 (web_admin) 2023.09.13 59
402 2022학년도 인제학술상 수상자 선정 결과 2023.01.05 관리자 2023.01.05 87
401 안전관리 우수연구실 인증 취득 2023.01.05 관리자 2023.01.05 56
400 한진교수 화의자의학상 수상 2023.01.05 관리자 2023.01.05 87
399 이온통로 학회 -Amy 포스터상 수상 2019.01.15 김형규 2019.01.15 2,597
398 센터 겸임교수 조성우 교수 - 한빛사 -JACC Vascular Imaging 2018.12.08 김형규 2018.12.08 2,803
397 2017 IMPACT Symposium 개최 첨부파일 2017.10.31 김보현 2017.10.31 2,598
396 경암바이오유스 2017 첨부파일 2017.08.11 김보현 2017.08.11 2,884
395 KORUS 2017 첨부파일 2017.06.21 김보현 2017.06.21 2,996
394 IMPACT 2016 심포지엄 개최 안내 첨부파일 2016.04.18 관리자 2016.04.18 4,010
393 IMPACT 2015 심포지엄 개최 안내 첨부파일 2015.04.20 서대윤 2015.04.20 2,878
392 2015 중점연구소 성과 전시회 첨부파일 2015.03.31 김형규 2015.03.31 2,471
391 Best Miso Award - 한진 2014.11.04 이정훈 2014.11.04 2,079
처음이전1 2 3 4 5 6 7 8 9 10 다음 마지막